Prescription drugs

Articles in this category:

• UK: Annual Report of the Chief Medical Officer Volume Two, 2011: Infections and the rise of antimicrobial resistance
  March 12, 2013 00:30
• Diagnosis and management of headaches in young people and adults
  September 19, 2012 22:04
• Australia. PLC Multi-Jurisdictional Guide 2012: Life Sciences
  May 24, 2012 14:34
• Health Care Cost and Utilization Report
  May 21, 2012 18:26
• Ensuring the Safety and Integrity of the World’s Drug, Vaccine, and Medicines Supply
  May 20, 2012 21:23
• China's Pharmaceutical Distribution: Poised for Change
  May 2, 2012 03:01
• Advances in FDA's Safety Program for Marketed Drugs
  April 24, 2012 18:50
• Biotechnology Innovation for Inclusive Growth
  April 15, 2012 15:46
• Academic-Industry Partnerships for Biopharmaceutical Research & Development: Advancing Medical Science in the U.S.
  April 15, 2012 01:43
• Global Diabetes Forum: Dubai Blueprint
  April 15, 2012 01:17
• Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad
  April 5, 2012 21:24
• Report to the Congress: Medicare Payment Policy
  March 17, 2012 13:37
• Trends in Retail Prices of Prescription Drugs Widely Used by Medicare Beneficiaries 2005 to 2009
  March 10, 2012 18:19
• Pandemic Vaccine Distribution Policy for the Twenty-First Century
  February 24, 2012 15:05
• Draft National Plan To Address Alzheimer's Disease
  February 23, 2012 14:02
• Guidance for Industry: Notification to FDA of Issues that May Result in a Prescription Drug or Biological Product Shortage
  February 21, 2012 16:34
• Direct to Consumer Internet Advertising of Statins: an Assessment of Safety
  February 8, 2012 14:45
• Medicare Beneficiary Savings and the Affordable Care Act
  February 4, 2012 15:53
• FDA Needs to Do More to Ensure That Drug Labels Contain Up-to-Date Information
  February 1, 2012 14:19
• Prescription Pain Reliever Abuse
  January 24, 2012 17:12